What can be learned from a chaotic cancer model?
暂无分享,去创建一个
[1] Alain Arneodo,et al. Occurence of strange attractors in three-dimensional Volterra equations , 1980 .
[2] Christophe Letellier,et al. Relation between observability and differential embeddings for nonlinear dynamics. , 2005, Physical review. E, Statistical, nonlinear, and soft matter physics.
[3] J. Yorke,et al. Antimonotonicity: inevitable reversals of period-doubling cascades , 1992 .
[4] Christophe Letellier,et al. Symbolic observability coefficients for univariate and multivariate analysis. , 2009, Physical review. E, Statistical, nonlinear, and soft matter physics.
[5] C. Letellier,et al. Unstable periodic orbits and templates of the Rossler system: Toward a systematic topological characterization. , 1995, Chaos.
[6] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[7] M. Tamburini,et al. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. , 1996, European journal of cancer.
[8] Avner Friedman,et al. Mathematical modeling of prostate cancer progression in response to androgen ablation therapy , 2011, Proceedings of the National Academy of Sciences.
[9] Yuri Kogan,et al. Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics , 2008, Cancer Immunology, Immunotherapy.
[10] Jae-Hyun Park,et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. , 2012, Cancer cell.
[11] H. Mellstedt,et al. Clinical results of vaccine therapy for cancer: learning from history for improving the future. , 2006, Advances in cancer research.
[12] Pierre Coullet,et al. ITÉRATIONS D'ENDOMORPHISMES ET GROUPE DE RENORMALISATION , 1978 .
[13] L. A. Aguirre,et al. Investigating observability properties from data in nonlinear dynamics. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.
[14] F. Denis,et al. Mise au pointThéorie du chaos en radiothérapie : la mésange et le papillon…Radiotherapy and chaos theory: The tit and the butterfly… , 2012 .
[15] Issam El Naqa,et al. Monte Carlo role in radiobiological modelling of radiotherapy outcomes , 2012, Physics in medicine and biology.
[16] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[17] J. Coste,et al. Asymptotic Behaviors in the Dynamics of Competing Species , 1979 .
[18] Zvi Fuks,et al. Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.
[19] T. Vincent,et al. An evolutionary model of carcinogenesis. , 2003, Cancer research.
[20] O. Rössler. An equation for continuous chaos , 1976 .
[21] A. Dudek,et al. Vaccine therapy for metastatic melanoma: systematic review and meta-analysis of clinical trials , 2011, Melanoma research.
[22] D. Karnofsky. The clinical evaluation of chemotherapeutic agents in cancer , 1949 .
[23] Robert A Gatenby,et al. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. , 2003, Molecular cancer therapeutics.
[24] Judith Campisi,et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B , 2012, Nature Medicine.
[25] F. Denis,et al. Théorie du chaos en radiothérapie : la mésange et le papillon… , 2012 .
[26] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[27] S. Tavazoie,et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells , 2011, Nature.
[28] J. Peyraud,et al. Strange attractors in volterra equations for species in competition , 1982, Journal of mathematical biology.
[29] M. Nowak,et al. Dynamics of cancer progression , 2004, Nature Reviews Cancer.
[30] Ami Radunskaya,et al. The dynamics of an optimally controlled tumor model: A case study , 2003 .
[31] J. Sprott,et al. Chaos in low-dimensional Lotka–Volterra models of competition , 2006 .
[32] Nicholas B. Tufillaro,et al. Experimental approach to nonlinear dynamics and chaos , 1992, Studies in nonlinearity.
[33] Stephen P. Banks,et al. Chaos in a Three-Dimensional Cancer Model , 2010, Int. J. Bifurc. Chaos.
[34] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[35] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[36] A. Perelson,et al. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.
[37] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[38] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[39] U. Foryś. Multi‐dimensional Lotka–Volterra systems for carcinogenesis mutations , 2009 .
[40] Christophe Letellier,et al. Interplay between synchronization, observability, and dynamics. , 2010, Physical review. E, Statistical, nonlinear, and soft matter physics.
[41] C. Conill,et al. Performance status assessment in cancer patients , 1990, Cancer.
[42] D. Kirschner,et al. Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.
[43] Ulrich Parlitz,et al. Bifurcation structure of bubble oscillators , 1990 .
[44] Michael E. Gilpin,et al. Spiral Chaos in a Predator-Prey Model , 1979, The American Naturalist.
[45] Luis A. Aguirre,et al. Observability of multivariate differential embeddings , 2005 .
[46] Luis A. Aguirre,et al. How the choice of the observable may influence the analysis of nonlinear dynamical systems , 2006 .
[47] F. Denis,et al. [Chaos theory: a fascinating concept for oncologists]. , 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[48] P. Schellhammer,et al. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] J. Fowler. The linear-quadratic formula and progress in fractionated radiotherapy. , 1989, The British journal of radiology.
[50] J. Nagy. Competition and natural selection in a mathematical model of cancer , 2004, Bulletin of mathematical biology.
[51] A. Krener,et al. Nonlinear controllability and observability , 1977 .
[52] M. Feigenbaum. Quantitative universality for a class of nonlinear transformations , 1978 .
[53] Luis A. Aguirre,et al. Investigating nonlinear dynamics from time series: The influence of symmetries and the choice of observables. , 2002, Chaos.